NKG2D CARs as Cell Therapy for Cancer
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cancer Research,Oncology
Reference10 articles.
1. Principles of adoptive T cell cancer therapy.;J Clin Invest,2007
2. Roles of the NKG2D immunoreceptor and its ligands.;Nat Rev Immunol,2003
3. NK cell recognition.;Annu Rev Immunol,2005
4. Chimeric NKG2D T cells require both T cell- and host-derived cytokine secretion and perforin expression to increase tumor antigen presentation and systemic immunity.;J Immunol,2009
5. Cancer immunotherapy using a bi-specific NK receptor-fusion protein that engages both T cells and tumor cells.;Cancer Res,2011
Cited by 85 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Efficacy of NKG2D CAR-T cells with IL-15/IL-15Rα signaling for treating Epstein-Barr virus-associated lymphoproliferative disorder;Experimental Hematology & Oncology;2024-08-19
2. CAR-T Cells in Acute Myeloid Leukemia: Where Do We Stand?;Biomedicines;2024-05-28
3. shRNA-mediated gene silencing of HDAC11 empowers CAR-T cells against prostate cancer;Frontiers in Immunology;2024-05-21
4. Prospects and challenges of CAR-T in the treatment of ovarian cancer;International Immunopharmacology;2024-05
5. A Roadmap of CAR-T-Cell Therapy in Glioblastoma: Challenges and Future Perspectives;Cells;2024-04-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3